Q: Better buy right now. HIMS or HROW? Thank you
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Is ibrx a reasonable company to make a small investment in?
Its treatment anktiva is approved for some cancers already and appears to have broader applications. The patents seem to have about 10 years to run.
Thank you for your research and opinion.
Its treatment anktiva is approved for some cancers already and appears to have broader applications. The patents seem to have about 10 years to run.
Thank you for your research and opinion.
Q: trying to decide between these two companies. PG does seem to have negative momentum. Is there more upside in PG or do you prefer JNJ or equal amounts of both?
Thanks Dave
Thanks Dave
Q: Hi Peter,
I have a question on Well Health and their Competition Bureau issue. Would it not be bullish for a company of Well's size to be considered to have a competitive edge on Telus, Loblaws et al considering it only has about 2% of the Primary Care clinics in Canada. I am wondering if this is an opportunity especially during tax loss.
I have a question on Well Health and their Competition Bureau issue. Would it not be bullish for a company of Well's size to be considered to have a competitive edge on Telus, Loblaws et al considering it only has about 2% of the Primary Care clinics in Canada. I am wondering if this is an opportunity especially during tax loss.
Q: XLV had a good run. Would you buy it here or wait for a pull back, Do you think that the healthcare sector has more momentum to the upside?
Thank. Cheers
Thank. Cheers
Q: Recent news shows WELL is going through court case. Can you explain what it is all about, likely out come and impact on share price.
-
WELL Health Technologies Corp. (WELL $4.14)
-
HealWELL AI Inc. Class A Subordinate Voting Shares (AIDX $0.90)
Q: Hello,
What is your analysis of the Competition Bureau investigation and what risks does it pose to Well's future performance?
Thanks
What is your analysis of the Competition Bureau investigation and what risks does it pose to Well's future performance?
Thanks
-
HealWELL AI Inc. Class A Subordinate Voting Shares (AIDX $0.90)
-
Westgold Resources Limited Ordinary shares (WGX $4.91)
Q: Hi there, can AIDX be considered dead on arrival now, for its IPO possibility next year?
The share price action has brought it down considerably during this tax loss selling season!
Where do you see support for the shares now?
Do you consider the shares priced fairly here at 1.00?
Current growth and outlook looks good, share price not so much, horrible!
I believe my question on WGX last week has gone MIA...your thoughts on their last quarter please?
Thanks!
The share price action has brought it down considerably during this tax loss selling season!
Where do you see support for the shares now?
Do you consider the shares priced fairly here at 1.00?
Current growth and outlook looks good, share price not so much, horrible!
I believe my question on WGX last week has gone MIA...your thoughts on their last quarter please?
Thanks!
Q: Have been following this interesting stock for a while now and would love a breakdown of it's merits and outlook and would you recommend a small position?
Q: Has NVO fallen to a level you see as attractive?
Q: Do you recommend moving on at this point given the buyout by Abbott? Would you consider waiting it out until 2026 to defer taxes?
Q: I’m considering selling WELL for a tax loss. And buying VHI as replacement for at least few months. Thoughts please?
Q: I first bought this in 2020, have added a few times and currently have not made a dollar. 5 years is a lot of 'wait time'. How much longer do I give this?
C.
C.
Q: Hello 5i
I realize it is very early in its public life but please tell me what you can about BLLN.
Thank you
Dave
I realize it is very early in its public life but please tell me what you can about BLLN.
Thank you
Dave
Q: What can you see for this little bio tech companies future Sellas life Sciences group. Their approach to cancer treatment or cures seems interesting but what does the business side look like.
Thanks
Thanks
Q: This healthcare tech stock just reported earnings, and appears to have beat on all marks. Yet the stock has dropped significantly since reporting. Wondering if you could give me your analysis if this is a good opportunity to buy relative to other healthcare tech, given its valuation metrics, support and resistance, and current growth trajectory. Any other similar small cap names in healthcare like this intrigue you right now?
Q: Drif largeting closer to < $1b market cap. Are there any clues of large, long term investors, especially the Chinese backers, slowly exiting their position?
Q: Can you explain reasons for WELL stocks dropping almost 20% while reporting quarterly performance. You always rated this company highly.
Q: Is this company profitable? Is it expensive? Do you see it as a hold, buy, or sell?
Thank you
Thank you
Q: TLT has recently announced promising results for Rutherin, the molecule it is testing. E.g. "Enhanced Tumor Destruction: Radiation-activated Rutherrin® achieved a 100-fold increase in cancer cell kill versus radiation therapy alone." But it is tiny, with a multi-year path to final results and depends on raising further capital. How can an investor assess companies like this, and what is your opinion of TLT re getting an investment toe in the door?